Effect of prolonged administration of clenbuterol on airway reactivity and sweating in horses with inflammatory airway disease

American Journal of Veterinary Research

Volumn 73, Issue 1, 2012, Pages 140-145

  Read, Jennifer R ^a,c   Boston, Raymond C ^a   Abraham, Getu ^b   Bauquier, Sebastien H ^a   Soma, Lawrence R ^a   Nolen Walston, Rose D ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF LEIPZIG   (Germany)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; CLENBUTEROL; HISTAMINE;

AIRWAY OBSTRUCTION; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG EFFECT; MALE; NONHUMAN; PLETHYSMOGRAPHY; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT INFLAMMATION; SWEATING; TACHYPHYLAXIS;

AIRWAY OBSTRUCTION; ANIMALS; BRONCHODILATOR AGENTS; CLENBUTEROL; CROSS-OVER STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; HISTAMINE; HORSE DISEASES; HORSES; HYPOHIDROSIS; PLETHYSMOGRAPHY; TACHYPHYLAXIS;

ANIMALIA; EQUIDAE;

EID: 84855275770     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.73.1.140     Document Type: Article

References (52)

1. Sasse HH, Hagejer R. NAB 365, a beta2-receptor sympathomimetic agent: clinical experiences in horses with lung disease. J Vet Pharmacol Ther 1978;1:241-243.
2. Erichsen DF, Aviad AD, Schultz RH, et al. Clinical efficacy and safety of clenbuterol HCl when administered to effect in horses with chronic obstructive pulmonary disease (COPD). Equine Vet J 1994;26:331-336.
3. Mair TS. Obstructive pulmonary disease in 18 horses at summer pasture. Vet Rec 1996;138:89-91.
4. Couetil LL, Hoffman AM, Hodgson J, et al. Inflammatory airway disease of horses. J Vet Intern Med 2007;21:356-361.
5. Burrell MH, Wood JL, Whitwell KE, et al. Respiratory disease in Thoroughbred horses in training: the relationships between disease and viruses, bacteria and environment. Vet Rec 1996;139:308-313.
6. Christley RM, Hodgson DR, Rose RJ, et al. Coughing in Thoroughbred racehorses: risk factors and tracheal endoscopic and cytological findings. Vet Rec 2001;148:99-104.
7. Wood JL, Newton JR, Chanter N, et al. Inflammatory airway disease, nasal discharge and respiratory infections in young British racehorses. Equine Vet J 2005;37:236-242.
8. Haney S, Hancox RJ. Recovery from bronchoconstriction and bronchodilator tolerance. Clin Rev Allergy Immunol 2006;31:181-196.
9. Cockcroft DW. Clinical concerns with inhaled beta2-agonists: adult asthma. Clin Rev Allergy Immunol 2006;31:197-208.
10. Scott JS, Berney CE, Derksen FJ, et al. β-Adrenergic receptor activity in ponies with recurrent obstructive pulmonary disease. Am J Vet Res 1991;52:1416-1422.
11. Perkins GA, Viel L, Wagner B, et al. Histamine bronchoprovocation does not affect bronchoalveolar lavage fluid cytology, gene expression and protein concentrations of IL-4, IL-8 and IFNgamma. Vet Immunol Immunopathol 2008;126:230-235.
12. Hoffman AM, Mazan MR, Ellenberg S. Association between bronchoalveolar lavage cytologic features and airway reactivity in horses with a history of exercise intolerance. Am J Vet Res 1998;59:176-181.
13. Hare JE, Viel L. Pulmonary eosinophilia associated with increased airway responsiveness in young racing horses. J Vet Intern Med 1998;12:163-170.
14. Laan TT, Bull S, Pirie RS, et al. The anti-inflammatory effects of IV administered clenbuterol in horses with recurrent airway obstruction. Vet J 2006;171:429-437.
15. van den Hoven R, Duvigneau JC, Hartl RT, et al. Clenbuterol affects the expression of messenger RNA for interleukin 10 inperipheral leukocytes from horses challenged intrabronchially with lipopolysaccharides. Vet Res Commun 2006;30:921-928.
16. Snow DH. Identification of the receptor involved in adrenaline mediated sweating in the horse. Res Vet Sci 1977;23:246-247.
17. Evans CL, Nisbet AM, Ross KA. A histological study of the sweat glands of normal and dry-coated horses. J Comp Pathol 1957;67:397-405.
18. Evans CL. Physiological mechanisms that underlie sweating in the horse. Br Vet J 1966;122:117-123.
19. Beadle RE, Norwood GL, Brencick VA. Summertime plasma catecholamine concentrations in healthy and anhidrotic horses in Louisiana. Am J Vet Res 1982;43:1446-1448.
20. Langley JN, Bennett S. Action of pilocarpine, arecoline and adrenaline on sweating in the horse. J Physiol 1923;57:71-72.
21. Rakhit S, Murdoch R, Wilson SM. Persistent desensitisation of the beta 2 adrenoceptors expressed by cultured equine sweat gland epithelial cells. J Exp Biol 1998;201:259-266.
22. Jenkinson DM, Elder HY, Bovell DL. Equine sweating and anhidrosis part 2: anhidrosis. Vet Dermatol 2007;18:2-11.
23. Soma LR, Uboh CE, Guan F, et al. Pharmacokinetics and disposition of clenbuterol in the horse. J Vet Pharmacol Ther 2004;27:71-77.
24. Nolen-Walston RD, Kuehn H, Boston RD, et al. Reproducibility of airway responsiveness in horses using flowmetric plethysmography and histamine bronchoprovocation. J Vet Intern Med 2009;23:631-635.
25. Hoffman A, Kuehn H, Riedelberger K, et al. Flowmetric comparison of respiratory inductance plethysmography and pneumotachography in horses. J Appl Physiol 2001;91:2767-2775.
26. Selvaraj V, Ariharathirurajkumar H, Bhuvanakumar CK. Semiquantitative sweat test in the diagnosis of equine anhidrosis. Indian Vet J 2001;78:790-792.
27. Spann C, Winter ME. Effect of clenbuterol on athletic performance. Ann Pharmacother 1995;29:75-77.
28. Peters AR. Beta-agonists as repartitioning agents: a review. Vet Rec 1989;124:417-420.
29. Kearns CF, McKeever KH, Malinowski K. Changes in adiponectin, leptin, and fat mass after clenbuterol treatment in horses. Med Sci Sports Exerc 2006;38:262-267.
30. Kearns CF, McKeever KH, Malinowski K, et al. Chronic administration of therapeutic levels of clenbuterol acts as a repartitioning agent. J Appl Physiol 2001;91:2064-2070.
31. Sleeper MM, Kearns CF, McKeever KH. Chronic clenbuterol administration negatively alters cardiac function. Med Sci Sports Exerc 2002;34:643-650.
32. Kearns CF, McKeever KH. Clenbuterol diminishes aerobic performance in horses. Med Sci Sports Exerc 2002;34:1976-1985.
33. Nishikawa M, Mak JC, Shirasaki H, et al. Differential down-regulation of pulmonary beta 1-and beta 2-adrenoceptor messenger RNA with prolonged in vivo infusion of isoprenaline. Eur J Pharmacol 1993;247:131-138.
34. Fredericks ZL, Pitcher JA, Lefkowitz RJ. Identification of the G protein-coupled receptor kinase phosphorylation sites in the human beta2-adrenergic receptor. J Biol Chem 1996;271:13796-13803.
35. Lohse MJ, Benovic JL, Codina J, et al. Beta-arrestin: a protein that regulates beta-adrenergic receptor function. Science 1990;248:1547-1550.
36. Abraham G, Schusser GF, Ungemach FR. Dexamethasoneinduced increase in lymphocyte beta-adrenergic receptor density and cAMP formation in vivo. Pharmacology 2003;67:1-5.
37. Abraham G, Kottke C, Dhein S, et al. Pharmacological and biochemical characterization of the beta-adrenergic signal transduction pathway in different segments of the respiratory tract. Biochem Pharmacol 2003;66:1067-1081.
38. Cockcroft DW, McParland CP, Britto SA, et al. Regular inhaled salbutamol and airway responsiveness to allergen. Lancet 1993;342:833-837.
39. Cheung D, Timmers MC, Zwinderman AH, et al. Long-term effects of a long-acting beta 2-adrenoceptor agonist, salmeterol, on airway hyperresponsiveness in patients with mild asthma. N Engl J Med 1992;327:1198-1203.
40. Yates DH, Sussman HS, Shaw MJ, et al. Regular formoterol treatment in mild asthma. Effect on bronchial responsiveness during and after treatment. Am J Respir Crit Care Med 1995;152:1170-1174.
41. Inman MD, O'Byrne PM. The effect of regular inhaled albuterol on exercise-induced bronchoconstriction. Am J Respir Crit Care Med 1996;153:65-69.
42. Jokic R, Swystun VA, Davis BE, et al. Regular inhaled salbutamol: effect on airway responsiveness to methacholine and adenosine 5′-monophosphate and tolerance to bronchoprotection. Chest 2001;119:370-375.
43. Derksen FJ, Scott JS, Slocombe RF, et al. Effect of clenbuterol on histamine-induced airway obstruction in ponies. Am J Vet Res 1987;48:423-426.
44. Myers TR. Guidelines for asthma management: a review and comparison of 5 current guidelines. Respir Care 2008;53:751-767.
45. Chung KF, Caramori G, Adcock IM. Inhaled corticosteroids as combination therapy with beta-adrenergic agonists in airways disease: present and future. Eur J Clin Pharmacol 2009;65:853-871.
46. Abraham G, Brodde OE, Ungemach FR. Regulation of equine lymphocyte beta-adrenoceptors under the influence of clenbuterol and dexamethasone. Equine Vet J 2002;34:587-593.
47. Broadstone RV, Gray PR, Robinson NE, et al. Effects of xylazine on airway function in ponies with recurrent airway obstruction. Am J Vet Res 1992;53:1813-1817.
48. Bijman J, Quinton PM. Predominantly beta-adrenergic control of equine sweating. Am J Physiol 1984;246:R349-R353.
49. Wilson SM, Pediani JD, Ko WH, et al. Investigation of stimulussecretion coupling in equine sweat gland epithelia using cell culture techniques. J Exp Biol 1993;183:279-299.
50. Kerr MG, Snow DH. Composition of sweat of the horse during prolonged epinephrine (adrenaline) infusion, heat exposure, and exercise. Am J Vet Res 1983;44:1571-1577.
51. Guthrie AJ, Van den Berg JS, Killeen VM, et al. Use of a semiquantitative sweat test in Thoroughbred horses. J S Afr Vet Assoc 1992;63:162-165.
52. MacKay RJ. Quantitative intradermal terbutaline sweat test in horses. Equine Vet J 2008;40:518-520.